Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus

about

Inflammation and the Silent Sequelae of Stroke.

P2860

Q38871034-0BA23CA7-DCD8-4FEB-B14A-F983A65E5774

P2860

Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus

Item

http://www.wikidata.org/entity/Q35942767

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@ast

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@en

type

Item

label

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@ast

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@en

prefLabel

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@ast

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@en

P1476

Pioglitazone is an effective t ...... with type 2 diabetes mellitus

@en

P2093

Haiyan Xing

http://www.w3.org/2001/XMLSchema#string

Jinbo Chen

http://www.w3.org/2001/XMLSchema#string

Lilin Gao

http://www.w3.org/2001/XMLSchema#string

Minghu Cui

http://www.w3.org/2001/XMLSchema#string

Wenxian Lu

http://www.w3.org/2001/XMLSchema#string

Xiaomeng Dong

http://www.w3.org/2001/XMLSchema#string

Xinxing Xiao

http://www.w3.org/2001/XMLSchema#string

Yaozhi Hu

http://www.w3.org/2001/XMLSchema#string

P2860

What causes the insulin resistance underlying obesity?

Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review.

Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

Poststroke depression: a review.

Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.

Variation in Functional Independence among Stroke Survivors Having Fatigue and Depression.

Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.

Sex differences in the prevalence of post-stroke depression: a systematic review.

Recognizing poststroke depression.

P304

1109-1114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2015.2593

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281197425

http://www.w3.org/2001/XMLSchema#string

P698

26622448

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4533146

http://www.w3.org/2001/XMLSchema#string

Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus

about

P2860

P2860

Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932